Share to Facebook Share to Twitter Bookmark and Share
File #: 150202    Version: 1 Name: Hearing - Specialty Tier Drug Pricing and Insurance Industry Practices
Type: Hearing Status: Filed
Introduced: 2/24/2015 In control: Budget and Finance Committee
On agenda: Final action: 11/29/2016
Enactment date: Enactment #:
Title: Hearing to review the current health insurance industry trend of reclassifying certain life-saving drugs, including drugs related to HIV/AIDS treatment, into a specialty tier, thereby significantly increasing the cost of and limiting access to those drugs for patients; and requesting the Department of Public Health, the Mayor's Office, Anthem Blue Cross of California, Blue Shield of California, Chinese Community Health Plan, Health Net of California, Kaiser Foundation Health Plan, Los Angeles Care Health Plan, Molina Healthcare of California, Sharp Health Plan, Valley Health Plan, Western Health Advantage, and other insurance providers doing business in San Francisco to report.
Sponsors: Scott Wiener
Attachments: 1. Comm Pkt 032515, 2. Ppt Presentation 032515, 3. DPH Ppt Presentation 032515
Legislation Details
 *NOTE: These reports are produced in HTML format and are accessible to screen readers.